61 – 70 of 210
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Högt ER-beta-uttryck starkt skyddande mot återfall hos de kvinnor som fått cytostatika
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Östrogenreceptor-beta kopplad till bättre prognos vid bröstcancer
(
- Contribution to journal › Article
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register
(
- Contribution to journal › Article
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
(
- Contribution to conference › Abstract
- 2016
-
Mark
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
(
- Contribution to journal › Article
-
Mark
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Sentinel lymph node biopsy staging for cutaneous malignant melanoma of the head and neck.
(
- Contribution to journal › Article